vs

Side-by-side financial comparison of POWER SOLUTIONS INTERNATIONAL, INC. (PSIX) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $191.2M, roughly 1.1× POWER SOLUTIONS INTERNATIONAL, INC.). POWER SOLUTIONS INTERNATIONAL, INC. runs the higher net margin — 8.4% vs 1.1%, a 7.3% gap on every dollar of revenue. On growth, POWER SOLUTIONS INTERNATIONAL, INC. posted the faster year-over-year revenue change (32.5% vs 4.9%). POWER SOLUTIONS INTERNATIONAL, INC. produced more free cash flow last quarter ($-7.6M vs $-26.8M). Over the past eight quarters, POWER SOLUTIONS INTERNATIONAL, INC.'s revenue compounded faster (41.7% CAGR vs 0.8%).

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

PSIX vs VREX — Head-to-Head

Bigger by revenue
VREX
VREX
1.1× larger
VREX
$209.6M
$191.2M
PSIX
Growing faster (revenue YoY)
PSIX
PSIX
+27.6% gap
PSIX
32.5%
4.9%
VREX
Higher net margin
PSIX
PSIX
7.3% more per $
PSIX
8.4%
1.1%
VREX
More free cash flow
PSIX
PSIX
$19.2M more FCF
PSIX
$-7.6M
$-26.8M
VREX
Faster 2-yr revenue CAGR
PSIX
PSIX
Annualised
PSIX
41.7%
0.8%
VREX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PSIX
PSIX
VREX
VREX
Revenue
$191.2M
$209.6M
Net Profit
$16.1M
$2.3M
Gross Margin
21.9%
33.3%
Operating Margin
12.7%
7.3%
Net Margin
8.4%
1.1%
Revenue YoY
32.5%
4.9%
Net Profit YoY
-31.0%
866.7%
EPS (diluted)
$0.69
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PSIX
PSIX
VREX
VREX
Q1 26
$209.6M
Q4 25
$191.2M
$228.9M
Q3 25
$203.8M
$203.0M
Q2 25
$191.9M
$212.9M
Q1 25
$135.4M
$199.8M
Q4 24
$144.3M
Q3 24
$125.8M
$205.7M
Q2 24
$110.6M
$209.1M
Net Profit
PSIX
PSIX
VREX
VREX
Q1 26
$2.3M
Q4 25
$16.1M
$12.2M
Q3 25
$27.6M
$-89.1M
Q2 25
$51.2M
$6.9M
Q1 25
$19.1M
$-300.0K
Q4 24
$23.3M
Q3 24
$17.3M
$-51.1M
Q2 24
$21.5M
$1.4M
Gross Margin
PSIX
PSIX
VREX
VREX
Q1 26
33.3%
Q4 25
21.9%
34.0%
Q3 25
23.9%
33.3%
Q2 25
28.2%
36.0%
Q1 25
29.7%
34.3%
Q4 24
29.9%
Q3 24
28.9%
32.6%
Q2 24
31.8%
32.0%
Operating Margin
PSIX
PSIX
VREX
VREX
Q1 26
7.3%
Q4 25
12.7%
8.6%
Q3 25
13.9%
-39.8%
Q2 25
16.9%
10.4%
Q1 25
18.2%
5.6%
Q4 24
17.5%
Q3 24
16.3%
5.3%
Q2 24
22.9%
4.4%
Net Margin
PSIX
PSIX
VREX
VREX
Q1 26
1.1%
Q4 25
8.4%
5.3%
Q3 25
13.5%
-43.9%
Q2 25
26.7%
3.2%
Q1 25
14.1%
-0.2%
Q4 24
16.1%
Q3 24
13.8%
-24.8%
Q2 24
19.5%
0.7%
EPS (diluted)
PSIX
PSIX
VREX
VREX
Q1 26
$0.05
Q4 25
$0.69
$0.29
Q3 25
$1.20
$-2.15
Q2 25
$2.22
$0.17
Q1 25
$0.83
$-0.01
Q4 24
$1.01
Q3 24
$0.75
$-1.25
Q2 24
$0.94
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PSIX
PSIX
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$41.3M
$125.6M
Total DebtLower is stronger
$96.6M
$367.6M
Stockholders' EquityBook value
$178.6M
$476.9M
Total Assets
$424.7M
$1.1B
Debt / EquityLower = less leverage
0.54×
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PSIX
PSIX
VREX
VREX
Q1 26
$125.6M
Q4 25
$41.3M
$155.1M
Q3 25
$49.0M
$152.6M
Q2 25
$49.5M
$223.0M
Q1 25
$50.0M
$212.6M
Q4 24
$55.3M
Q3 24
$40.5M
$200.5M
Q2 24
$28.8M
$190.0M
Total Debt
PSIX
PSIX
VREX
VREX
Q1 26
$367.6M
Q4 25
$96.6M
$367.5M
Q3 25
$96.7M
$367.5M
Q2 25
$1.8M
$567.2M
Q1 25
$1.0M
$567.0M
Q4 24
$184.0K
Q3 24
$238.0K
$443.4M
Q2 24
$292.0K
$443.1M
Stockholders' Equity
PSIX
PSIX
VREX
VREX
Q1 26
$476.9M
Q4 25
$178.6M
$472.6M
Q3 25
$162.5M
$455.3M
Q2 25
$135.7M
$549.7M
Q1 25
$84.3M
$540.2M
Q4 24
$65.3M
Q3 24
$42.1M
$529.1M
Q2 24
$24.8M
$581.2M
Total Assets
PSIX
PSIX
VREX
VREX
Q1 26
$1.1B
Q4 25
$424.7M
$1.1B
Q3 25
$458.9M
$1.1B
Q2 25
$437.7M
$1.4B
Q1 25
$372.7M
$1.3B
Q4 24
$328.2M
Q3 24
$339.1M
$1.2B
Q2 24
$307.6M
$1.3B
Debt / Equity
PSIX
PSIX
VREX
VREX
Q1 26
0.77×
Q4 25
0.54×
0.78×
Q3 25
0.60×
0.81×
Q2 25
0.01×
1.03×
Q1 25
0.01×
1.05×
Q4 24
0.00×
Q3 24
0.01×
0.84×
Q2 24
0.01×
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PSIX
PSIX
VREX
VREX
Operating Cash FlowLast quarter
$-4.6M
$-16.1M
Free Cash FlowOCF − Capex
$-7.6M
$-26.8M
FCF MarginFCF / Revenue
-4.0%
-12.8%
Capex IntensityCapex / Revenue
1.6%
5.1%
Cash ConversionOCF / Net Profit
-0.29×
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$14.1M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PSIX
PSIX
VREX
VREX
Q1 26
$-16.1M
Q4 25
$-4.6M
$7.9M
Q3 25
$3.3M
$7.7M
Q2 25
$16.7M
$16.6M
Q1 25
$8.8M
$9.5M
Q4 24
$32.7M
Q3 24
$12.6M
$25.9M
Q2 24
$1.5M
$8.0M
Free Cash Flow
PSIX
PSIX
VREX
VREX
Q1 26
$-26.8M
Q4 25
$-7.6M
$2.3M
Q3 25
$1.7M
$1.4M
Q2 25
$14.6M
$9.8M
Q1 25
$5.4M
$5.3M
Q4 24
$30.0M
Q3 24
$12.1M
$19.9M
Q2 24
$822.0K
$3.3M
FCF Margin
PSIX
PSIX
VREX
VREX
Q1 26
-12.8%
Q4 25
-4.0%
1.0%
Q3 25
0.8%
0.7%
Q2 25
7.6%
4.6%
Q1 25
4.0%
2.7%
Q4 24
20.8%
Q3 24
9.7%
9.7%
Q2 24
0.7%
1.6%
Capex Intensity
PSIX
PSIX
VREX
VREX
Q1 26
5.1%
Q4 25
1.6%
2.4%
Q3 25
0.8%
3.1%
Q2 25
1.1%
3.2%
Q1 25
2.5%
2.1%
Q4 24
1.8%
Q3 24
0.3%
2.9%
Q2 24
0.6%
2.2%
Cash Conversion
PSIX
PSIX
VREX
VREX
Q1 26
-7.00×
Q4 25
-0.29×
0.65×
Q3 25
0.12×
Q2 25
0.33×
2.41×
Q1 25
0.46×
Q4 24
1.40×
Q3 24
0.73×
Q2 24
0.07×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons